Skip to main content
OpenTrials
Completed

NCT Number: NCT02580513

Circadian Misalignment and Insulin Sensitivity

This study will evaluate the effect of circadian misalignment on insulin sensitivity in healthy lean subjects in a randomized cross-over design. Subjects will be admitted to the research facility for two study periods of 3 and 3.5 days. In one of the study periods, the behavioral cycle will be shifted by 12 hours. Insulin sensitivity will be measured with a hyperinsulinemic euglycemic clamp.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–35 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Maastricht University

Maastricht, Netherlands

About this study

Recent evidence shows that misalignment of the circadian rhythm (e.g. by rotating shift work) impairs glucose metabolism markedly, possibly by decreasing insulin sensitivity in peripheral tissues and liver. Nowadays our society is indispensably connected to a lifestyle that allows wakefulness at every time of the 24 hours cycle. Social jetlag is a phenomenon that affects a large part of the general population, thus circadian misalignment extends far beyond those who are on a shift work schedule. Therefore, decreased insulin sensitivity in individuals affected by circadian misalignment may help to explain the increased prevalence of T2DM in night shift workers that has been found in epidemiological studies.

The study is an interventional randomized crossover trial in which each subject serves as it owns control. For the study, the investigators ask the subjects to participate in two study periods, one of 3 days length (control condition) and the other of 3.5 days length (misalignment condition). During the 3.5 day misalignment condition, subjects will shift their day-night rhythm by 12 hours, which will lead to maximal circadian misalignment. Insulin sensitivity will be measured by a hyperinsulinemic euglycemic clamp. Secondary parameters will include ex-vivo skeletal muscle mitochondrial function and whole-body energy metabolism.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Caucasian
  • Healthy (as determined by dependent physician based on medical questionnaire)
  • Male
  • Age: 18-35 years
  • Normal BMI (18-25 kg/m2)
  • Regular sleeping time (normally 7 - 9h daily)
  • Habitual bedtime at 11 PM ± 2 hours

Exclusion criteria

  • Extreme early bird or extreme night person
  • Heavily varying sleep-wake rhythm
  • Shiftwork during last 3 months
  • Travel across >1 time zone in the last 3 months
  • Engagement in exercise > 3 hours total per week
  • Using > 400mg caffeine daily
  • Smoking
  • Unstable body weight (weight gain or loss > 3kg in the last 3 months)
  • Significant food allergies/intolerance (seriously hampering study meals)
  • Participation in another biomedical study within 1 month before the first study visit
  • Claustrophobia
  • Medication use hampering the study (as determined by responsible physician)
  • Recent blood donation.
  • Any contra-indication to the telemetric pill:
  • Any acute condition, exacerbation of chronic condition, or medical history that would in the investigator's opinion interfere with the study

Treatment and study plan

Circadian Misalignment

Behavioral

Primary outcomes

  1. Insulin Sensitivity

    Time frame: 2 days after circadian misalignment and matched time in control arm.

    Measured with hyperinsulinemic euglycemic clamp

Secondary outcomes

  1. Oxidative glucose disposal

    Time frame: 2 days after circadian misalignment and matched time in control arm.

  2. Non-oxidative glucose disposal

    Time frame: 2 days after circadian misalignment and matched time in control arm.

  3. Skeletal muscle mitochondrial function

    Time frame: 1 and 2 days after circadian misalignment and matched times in control arm

    Measured with high-resolution respirometry on permeabilized muscle fibers after muscle biopsy

  4. Whole body energy metabolism while awake

    Time frame: 1 and 2 days after circadian misalignment and matched times in control arm

    Measured by indirect calorimetry

  5. Sleeping metabolic rate

    Time frame: 1.5 days after circadian misalignment and matched time in control arm

    Measured by indirect calorimetry

  6. Skeletal muscle mtDNA

    Time frame: 1 and 2 days after circadian misalignment and matched times in control arm

    Measured by qPCR

  7. Skeletal muscle mRNA

    Time frame: 1 and 2 days after circadian misalignment and matched times in control arm

    Measured by qPCR and Western Blotting

  8. Skeletal muscle proteins

    Time frame: 1 and 2 days after circadian misalignment and matched times in control arm

    Measured by Western Blotting

  9. Metabolic compounds in the blood (e.g. glucose, insulin, FFA's, Triglycerides, cholesterol)

    Time frame: 1 and 2 days after circadian misalignment and matched times in control arm

  10. Core-body-temperature

    Time frame: 1 day after circadian misalignment and matched time in control arm

    Measured by a telemetric pill

  11. Peripheral skin temperature

    Time frame: 1 day after circadian misalignment and matched time in control arm

    Measured by skin temperature sensors

  12. Central skin temperature

    Time frame: 1 day after circadian misalignment and matched time in control arm

    Measured by skin temperature sensors

  13. Heart rate

    Time frame: 1 day after circadian misalignment and matched time in control arm

    Measured by heart rate monitor

Sponsors and collaborators

Lead sponsor

Maastricht University Medical Center

Other

Registry information

Official study title

Impact of Circadian Misalignment on Insulin Sensitivity

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Oct 20, 2015
Registry last updated
Jun 9, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.